Introduction
type, 14 or as a cytotoxic gene product to interfere with The use of percutaneous transluminal coronary angiocellular metabolism. 15 plasty (PTCA) has increased greatly over the past 10 However, many of these strategies are hampered by years. However, the long-term luminal restenosis rate has the low transfection efficiencies of present protocols. remained constant at 30 to 50%, despite drug regimens Many protocols involving cationic liposomes for the which have been used in an attempt to control it. 1, 2 The delivery of DNA, [16] [17] [18] [19] 21 or antisense oligonucleoexact cause of restenosis remains controversial, although tides 11, 12, 22 into cells and tissues have been described in the migration and overproliferation of vascular smooth vitro and in vivo. 23 Indeed, the protocols have progressed muscle cells (VSMCs) and simultaneous production of to the point where a number of human gene therapy extracellular matrix have been implicated. [3] [4] [5] This process trials have been devised utilising cationic liposomes to is proposed to be due to an exaggerated healing response facilitate gene delivery, 24, 25 although none yet target and vascular remodelling by the vessel following PTCAcardiovascular disease. induced damage. In support of this hypothesis, examinCationic liposomes have a number of potential advanation of restenosed vessels has shown high-level tages over viral gene delivery systems. These include the expression of proliferating cell nuclear antigen (PCNA) ability to use a range of gene constructs from simple plasand other growth markers in smooth muscle cells. 6, 7 mids to chromosomal fragments; the potential for cell-A number of strategies for gene therapy have been sugspecific targeting (based on the narrow efficiency wingested which may prevent the progressive proliferation dows for different cell lineages); reduced safety concerns of VSMCs and alleviate the problem of restenosis. 8, 9 The relative to those associated with viral genomes; easier antisense approach involves the use of synthetic oligotransfection protocols and less propensity to induce an nucleotides or expression constructs designed to produce immune response in vivo. 23, [26] [27] [28] [29] [30] [31] nucleic acids complementary in sequence to target The mechanism by which cationic liposomes mediate growth-associated genes in order to block their transtheir activity relies on neutralizing the negative charge lation by a variety of mechanisms. [10] [11] [12] [13] Alternatively, of the DNA intended for transfection. This results in a entire genes have been inserted into cells, either being condensation reaction and the formation of stable complexes with a net positive charge which then associate with the negatively charged surface of the cell. 32, 33 this is macromolecule delivery to the cytoplasm while avoiding fusion with lysosomes and subsequent degraapplied to the cells for the appropriate period, following which it was removed and the cells cultured in complete dation. 34 The Tfx™-50 reagent utilised in these experiments is a mixture of a synthetic cationic lipid molmedium for 48 h before harvesting and enzymatic analyses. The results ( Figure 2) show that luciferase activity is ecule (N,N,N′,N′-tetramethyl-N, N′-bis(2-hydroxyethyl)-2,2,-dioleoyloxy-1,4-butanediammonium iodide) and ldetectable even when the transfection time is as short as 5 min and this activity increases with extension of transdioleoylphosphatidylethanolamine (DOPE). 35 The use of DOPE is common to many cationic liposome formufection time. A plateau of luciferase activity is reached for each lineage such that increasing the time within the lations and its role is to facilitate the membrane fusion or destabilisation step in macromolecule delivery. 34, 36 parameters studied results in no increase in transfection. Parallel experiments utilising a 2-h exposure of each Studies on the mechanism of Tfx™-50-mediated gene transfection indicate that it is not mediated by acidic population to naked DNA at the same concentration produced no detectable luciferase expression indicating that endocytotic vesicles. 37 Hence it is classed as a 'cytofectin', which describes the ability of a compound to facilitate it is the presence of the Tfx™-50 in the transfection mix which is mediating the transfection as opposed to the macromolecule entry into living cells while avoiding the lysosomal pathway. 22, 34 vector being taken up via an alternative mechanism. Although the application of physical gene transfection techniques has begun to show promise, the efficiency of Toxicity of Tfx™-50 or Tfx™-50-plasmid DNA complexes introduction of foreign DNA probably falls short of that required for effective gene therapy for vascular disease.
The optimised conditions determined for a panel of populations were applied to determine whether the However, this could depend to a large extent on whether the gene product is cell-localised or secreted to mediate Tfx™-50-DNA complexes have a toxic effect. Comparisons were made in each case to nontransfected and Tfx™-its effects on the surrounding population. 38, 39 Additional difficulties have been encountered because each cell type 50 only controls. Relative toxicity was then determined 48 h later by comparing the proliferation level of each from each species has a characteristic set of optimal transfection conditions which complicates the translation of population assayed following a 4-h pulse labelling with tritiated thymidine. There is no significant difference in results from model systems to clinical applications and vice versa. To determine the optimal transfection conthe level of thymidine incorporation between transfected and nontransfected human and rabbit smooth muscle ditions for the introduction of foreign genes into vascular cells, the present studies were carried out for a number cells (95% confidence interval). However HUVECs and rat SMCs do exhibit reductions in incorporation of vascular lineages from different species using the new liposome compound Tfx™-50.
35
(approximately 10 and 25% respectively) indicating that the transfection complexes have a significant toxic effect on these populations. Certain lines do exhibit a major Results toxic response to Tfx™-50-DNA complexes; it proved impossible to optimise transfection in the L6 rat skeletal Gene transfection in vitro -optimization of transfection muscle myoblast cell line due to rapid cell death followconditions in cultured cells ing exposure to the complexes (data not shown). The efficiency of various transfection conditions for rabbit, rat and human arterial smooth muscle cells (SMCs),
Immunohistochemical analyses human umbilical vein endothelial cells (HUVECs) and Luciferase activity analyses of a transfected population the human VSMC (ATCC CRL-1999) cell line have been do not indicate whether all the cells or merely a subpopdetermined using Tfx™-50 and the pGL3 luciferase veculation have been successfully transfected. For this reators. The conditions used for the HepG2 cell line were as son immunohistochemical analyses were performed. previously described. 35 The transfection optimisation for Populations were transfected with the pGL3 control three representative populations (human aortic smooth luciferase vector utilising optimal or suboptimal conmuscle cells, HUVECs and the HepG2 cell line) are ditions (reduction in amount of vector DNA, all other shown in Figure 1 . These demonstrate that: (1) the transvariables constant) as previously determined by enzyfection profile for each population varies; and (2) a narmatic analyses. The populations were then assayed for row window for efficient transfection exists -conditions luciferase expression 48 h after transfection. Under the outside those optimal can result in a dramatic reduction tested conditions Ͼ85% of rabbit VSMCs express the of luciferase activity. Unlike the HepG2 cell line which luciferase protein at 48 h, while use of the higher concenwas successfully transfected in the presence of serum, we trations of vector DNA (to optimal) results in a greater observed that luciferase activity in the other lineages was level of luciferase expression per cell (Figure 3a -c). Condramatically reduced under these conditions. For intratrol rabbit VSMCs cells transfected with the promoterless population comparisons the luciferase enzymatic activity pGL3 basic luciferase vector under the same conditions derived from each following a representative transfection show no luciferase expression ( Figure 3d ). Similar analyunder relevant optimal conditions is shown (Table 1) .
ses performed on rat and human VSMCs and the HepG2 Transfection efficiency in these experiments is determcell line show that a lower percentage of cells (у30%) in ined by enzymatic analyses of luciferase activity.
these populations express luciferase (Table 2 ) when transfected under optimal conditions. Time course: transfections In order to determine the time course of DNA uptake Transfection analyses on human arteries in vitro The previous experiments have shown that following under the optimised conditions, a series of transfection analyses were performed. In these experiments the transoptimisation, Tfx™-50 mediated transfection efficiently facilitates gene delivery into cell monolayers. However if fection solution (Tfx™-50:pGL3 control luciferase) was the protocol is to be successfully applied to a gene therby grossly visible atherosclerotic plaques) were assayed. Analyses on vessel segments fixed 48 h after transfection apy situation it is essential that it should be applicable to intact tissues. A series of human vessels were obtained show strong luciferase expression in the cells of the intimal layer with scattered staining in cells of the medial from transplant donors and transfected as described utilising conditions determined as optimal from the rellayer (Figure 4 a, c and d). The luciferase expression in these cells is localised in the cytoplasm, with the nonfluevant isolated cells (human VSMCs, Table 1 ). Both normal and atherosclerotic vessel segments (as determined orescent nucleus being clearly outlined (indicated). Non- ical analyses of the transfected arteries show the majority to exhibit luciferase expression localised to the intimal layer (Figure 5a ) while in some cases strong luciferase expression which penetrates through the internal elastic lamina into the media is seen (Figure 5b ). Nontransfected its tight junctions such that those vessels which exhibit deep penetrance have had the endothelial layer damaged as a consequence of the transfection procedure utilised. transfected vessel sections analysed using the same protocol show no detectable staining (Figure 4b ). This is supported by the colocalisation of von Willebrand factor (vWf) (indicating the presence of endothelial cells) and luciferase expression in a vessel which exhibits Transfection analyses on rabbit common carotid arteries in vivo intimal luciferase expression (Figure 6 , inset). To determine the transfection efficiency and extent of penetrance of the Tfx™-50-DNA complexes into the rabDuration of gene expression The peak of gene expression following transient transfecbit common carotid artery in an in vivo situation, experiments were performed as described. Immunocytochemtion is generally acknowledged to occur at 48-96 h and reduce thereafter as the episomal gene constructs are transferase (CAT) into vascular cells in vitro, 39, 40 or into the vascular wall in vivo 18, 41, 42 is possible. In this investidegraded. Experiments were performed to determine the level of luciferase gene expression after this time utilising gation we have verified that using a new commercially available liposome, Tfx™-50, it is possible to transfer the the Tfx™-50 protocol. Human and rabbit vessel sections were analysed for luciferase expression by immunohistoluciferase gene to various vascular cells both in vitro and in vivo at higher efficiencies than previously reported for chemistry 5 and 10 days after transfection as described (Figures 6 and 7) . Both the human and rabbit arteries a complex of this type. 32, 40, 43 The DNA concentration, the ratio of liposome to DNA (which affects the net charge show strong luciferase expression at day 5 (Figures 6a  and 7a ). At day 10 however a dramatic reduction in of the complexes formed), the transfection time and the effect of serum are the most critical factors in each transluciferase expression is readily apparent in rabbit carotid arteries (Figure 6b ) relative to the earlier time-points fection, and some of the conditions vary depending on the lineage tested. (Figure 6a ), while human vessels analysed for luciferase expression 5 or 10 days after transfection are indisPrevious in vivo transfection analyses utilising liposomes have been performed to transfer reporter genes tinguishable (Figure 7a and c) .
into the vessel walls of intact animals, but with disappointing results. The reasons for the lower transfection Discussion efficiencies than those recorded in in vitro analyses are not clear, but may be related to a number of factors: (1) Recent studies indicate that the use of cationic liposomes the optimal transfection conditions for vascular cells in to facilitate the functional delivery of reporter genes such as luciferase, ␤-galactosidase or chloramphenicol acetyl vitro may not correspond to those in vivo or the optimal plexes with serum proteins such as lipases, or a blocking effect by the glycocalyx layer which covers the luminal surface of intact vessels. The efficiency of luciferase expression following the transfection of intact vessels is encouraging but raises a number of questions: why do certain cells deep within the vessel express high levels of luciferase while their neighbours are apparently nontransfected? The majority of positive cells have a classical contractile phenotype, being elongated in shape. It is possible that the efficiency of transfection is clonal in nature and this is currently being investigated. Previous studies utilising liposomemediated transfection of isolated vascular smooth muscle cells has shown differences in DNA uptake dependent on whether the cells came from healthy tissue, atherosclerotic plaque or restenotic lesions, 40 which further supports this possibility.
The in vivo experiments described herein involve a relatively nontraumatic transfection protocol (isolate and dwell). It may be possible to increase the transfection efficiency still further by incorporation of other approaches such as: (1) catheter-mediated gene delivery using a double balloon system; (2) the exploitation of systems which have been used successfully to improve cationic liposome-mediated gene transfection, such as complexing with polylysine conjugates, inactivated Sendai virus or adenovirus particles, AAV-based plasmids or cholesterol. 32, [44] [45] [46] Using the protocol we describe, transfection of intact vessels is not only possible but efficient. In summary: (1) gene transfection occurs within 5 min and gene expression is present in 30-85% of cells in an optimally transfected cell monolayer in vitro; (2) the transfection complexes appear to traverse the endothelial and internal elastic lamina in undamaged vessels; (3) toxicity is not excessive in vitro not in vivo; (4) luciferase expression is still easily detectable 10 days after transfection. Taken together these results suggest that these optimised conditions for gene transfer into vascular cells with Tfx™-50 will be valuable for molecular analyses requiring transfection and gene therapy approaches to treat cardiovascular diseases such as restenosis.
Materials and methods

Materials
Tfx™-50 and the luciferase assay system were purchased from Promega (Southampton). Directly conjugated polyclonal rabbit anti-luciferase*FITC and polyclonal rabbit anti-luciferase antibodies were purchased from Europa Wycombe, UK). The pGL3 luciferase control vector (SV40 promoter and enhancer) and pGL3 luciferase basic vector (promoterless and enhancerless) were purchased from conditions obtained from different types of tissues may not be similar to those of animal arteries; (2) the transfecPromega, transformed into E. coli (JM109) and purified on Qiagen-500 (Qiagen, Surrey, UK) columns before tion of liposome-DNA mixtures into cell monolayers in serum-free medium in vitro reflects a different condition transfection. Heat-inactivated FCS was purchased from Harlan Seralabs (Crawley Down, UK). Medium and supto exposure to DNA injected into the lumen of target arteries during gene transfer in vivo. This could be due plements were purchased from Gibco Life Technologies (Paisley, UK). Tritiated thymidine ( 3 H-TdR) was to inhibitory in vivo interactions of the transfection com- purchased from Amersham Life Science (Amersham, p15; human SMCs: DMEM, 10% FCS, 10% CO 2 , p2-p8; HUVECs, M199, 10% FCS, 5% CO 2 , 20 g/ml ECGF, UK). Human arteries were kindly provided by King's College Hospital Liver Transplant Unit, London, UK, 80 g/ml heparin, fungizone, p2-p8. The HepG2 cell line was grown in DMEM, 10% FCS, 5% CO 2 . The cultures from organ transplant donors with the consent of relatives.
were maintained at 37°C in a humidified incubator with CO 2 as described. All cultures also contained penicillin, streptomycin and l-glutamine as standard. For these Cell culture and transfection Smooth muscle cells from rabbit and rat aorta, or human studies, cell cultures were maintained in the exponential growth phase and used between the passages described. arteries (aorta, inferior mesenteric or splenic), and endothelial cells from human umbilical veins (HUVECs) were Cells for transfection were plated at 5 × 10 4 cells per well in 12-or 24-well plates (dependent on cell size) 2 days routinely grown as follows: rabbit SMCs: M199, 10% FCS, 1% nonessential amino acids (NEAA), 5% CO 2 , passage before transfection. On the day of transfection the medium was aspirated and the cells were washed twice 2 (p2) only; rat SMCs: DMEM, 10% FCS, 10% CO 2 , p8- in serum-free DMEM or M199. To optimize the Tfx™-50-min, 3 min at 37°C) and centrifuged at 10 000 g in a benchtop microfuge for 2 min. Supernatants were then mediated transfection conditions, triplicate cultures were incubated as appropriate according to the conditions stored at −20°C until the luciferase assays were performed. shown (Table 1) . After the appropriate length of time, 1.0 to 1.5 ml of 10% DMEM or M199 was added per well For enzymatic analyses, 40 l of the supernatant was mixed in 100 l of luciferase assay buffer and the light and cells were cultured for 48 h before assaying for luciferase activity.
units produced immediately measured on a luminometer (Turner Designs luminometer model 20e). Data (in light units) are the mean of triplicates with the standard error Assay of luciferase activity Luciferase activity was measured as described in the of the mean also shown. manufacturer's instructions (Promega). Briefly, cells were washed twice in PBS (Ca 2+ and Mg 2+ free), and then harTransfection of rabbit carotid arteries in vivo Twelve 16-to 18-week-old male rabbits (brown half-lop vested in 100-150 l of cell lysis buffer (for 24-or 12-well plates respectively). The resulting cell extracts were then or New Zealand White (NZW), mean weight 3080 g, range 2860-3499 g) were anaesthetized with halothane subjected to three rounds of freeze-thaw (liquid N 2 for 3 (2%) (fluranisone 10 mg/ml and fentanyl citrate 0.315
Immunocytochemical studies For immunocytochemical studies of cell lines and primg/ml) in nitrous oxide/oxygen via nose cone or endotracheal tube after induction with 10 mg methoheximary cultures 5 × 10 4 cells were grown on coverslips in 12-or 24-well plates and transfected as above. Forty-eight tone sodium intravenously (i.v.) via the ear vein. Heparin (300 U/kg) was administered i.v. The right common hours after transfection, the coverslips overlaid with a cell monolayer were rinsed briefly in PBS, fixed for 10 carotid artery was surgically exposed and dissected free of the vagus nerve. The experimental segment min in methanol at −20°C, air dried at room temperature for 5 min and stored desiccated at −20°C. (approximately 2 cm in length) was then isolated by means of soft, nontraumatic microvascular clamps and Immediately before staining, coverslips were rinsed briefly in PBS and cells permeabilised by immersion for flushed with serum-free M199. The transfectant solution (2.5 g/ml pGL3 control luciferase vector, Tfx™-50 ratio 10 min in 0.1% saponin. Coverslips were then drained thoroughly and placed in a humid chamber. Sixty 4:1) was directly instilled into the isolated vessel segment with a 30 gauge needle, and allowed to remain for 30 microlitres of the primary antibody solution (affinity-purified rabbit anti-luciferase, 1:50 in PBS, 0.5% BSA, 0.01% min (the 'dwell' technique). At the end of this period, the clamps were removed and free flow of blood to the vessel sodium azide) was added to each coverslip and incubated overnight at 4°C. The excess antibody solution was was restored which washed the remaining transfection complexes into the circulation. The wound was closed then removed and the coverslips dipped briefly in PBS and rinsed in three changes of PBS for 5 min with gentle with 4.0 subcutaneous vicryl (J & J, Ascot, UK) sutures, dusted with 2% chlortetracycline hydrochloride antibiotic agitation. Sixty microlitres of the second antibody (goat anti rabbit IgG*FITC, 1:100) was added per coverslip and powder and the rabbits were allowed to recover from anaesthesia and returned to their cages. In addition to the then incubated for 1 h at room temperature followed by washing as above. Each coverslip was then inverted on above, the 5 and 10 day survival rabbits were given 0.5 ml of a solution of trimethoprim 40 mg/ml, sulphadiazto a small drop Vectashield antifading mountant on a clean glass slide and observed using a laser confocal ine 200 mg/ml subcutaneous antibiotic. Free access to food and water was allowed and analgesia given as microscope (BioRad MRC 600, Hemel Hempstead, UK). For histochemical studies of rabbit and human vessels, required.
After the appropriate period of time (2, 5 or 10 days), the sections were rinsed briefly three times in PBS, permeabilised for 30 min in 0.2% triton-X100, blocked for 1 h the rabbits were premedicated with 0.25 mg intramuscular (i.m.) fluanisone 10 mg/ml and 0.3 ml i.v. heparin with 5% horse serum in PBS and drained thoroughly. Fifty microlitres of directly conjugated anti-luciferase* (5000 IU/ml) and killed by standard i.v. barbiturate overdose (8 ml pentabarbitone sodium, 60 mg/ml), and the FITC antibody (1:50) was added and the slides were incubated in darkness overnight at 4°C. The slides were then experimental segments of vessel were removed for incubation and examination by histochemical analyses. The washed three times in PBS and mounted in a 1:1 mixture of PBS:glycerol. Analyses were performed by confocal negative control for each rabbit was the untreated left common carotid vessel. Arteries were sectioned into microscopy as described. three or four serial segments each approximately 3 mm in length. The segments were embedded in OCT embedding Proliferation assays Proliferation was measured by tritiated thymidine medium (Bayer, London, UK) and frozen immediately in isopentane cooled with liquid N 2 . For immunocytochem-(methyl-3 H-TdR) incorporation as assayed by liquid scintillation spectroscopy in a betaplate counter. Cells for ical staining, 5 m cryosections were cut, airdried for 1 h at room temperature, rinsed three times with PBS for 5 proliferation assays were plated and transfected as described above, with the difference that the transfection min each and fixed for 30 min in methanol at −20°C.
assays were performed in sextuplet rather than triplicate. Each well was pulsed with 2 Ci/ml (methyl-3 H-TdR) Transfection of human arteries in vitro Human vessels (aorta, inferior mesenteric and splenic 40-48 h after treatment. Four hours after the pulse, the cells were rinsed twice with PBS, and washed three times arteries) were provided by Kings College Hospital within 12 h of removal from transplant donors. Following diswith 5% trichloroacetic acid (TCA). Following this the wells were rinsed with 70% ethanol, air dried and stored section and the removal of connective tissue the vessel was divided into flat sections (approximately 9 × 3 mm)
at −20°C until analysis. For scintillation counting, the cell monolayers were suspended by incubation in 400 l 0.25 which were rinsed briefly in serum-free DMEM, placed in transfection solution (2.5 g/ml pGL3 control luciferm NaOH at 37°C for 1 h with gentle shaking. Samples were then transferred to scintillation vials, 4 ml of Optiase vector, Tfx™-50 ratio 4:1) sufficient to cover the segments for 30 min to 2 h and finally overlaid with comphase Hisafe scintillation cocktail (Wallac, Milton Keynes, UK) was added and the vials were assayed. plete DMEM. After the appropriate incubation period (2, 5 or 10 days at 37°C, 5% CO 2 with medium changes every Results are expressed as mean counts per minute (c.p.m.) of the sextuplet samples with the standard error of the 2 to 3 days), the segments were harvested and bisected. Segments were washed three times with PBS, fixed in mean. Zamboni's fixative (0.1 m phosphate buffer pH 7.2, 1% paraformaldehyde (PFA), 15% picric acid) for 90 min at
